ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minamiya, Y.
Right arrow Articles by Ogawa, J.-i.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minamiya, Y.
Right arrow Articles by Ogawa, J.-i.
Related Collections
Right arrow Lung - cancer

Ann Thorac Surg 2006;81:327-330
© 2006 The Society of Thoracic Surgeons


New technology

Intraoperative Sentinel Lymph Node Mapping Using a New Sterilizable Magnetometer in Patients with Nonsmall Cell Lung Cancer

Yoshihiro Minamiya, MD, PhD * , Manabu Ito, MD, Yoshihisa Katayose, MD, PhD, Hajime Saito, MD, PhD, Kazuhiro Imai, MD, Yusuke Sato, MD, Jun-ichi Ogawa, MD, PhD

Division of Thoracic Surgery, Department of Surgery, Akita University School of Medicine, Hondo Akita City, Japan

Accepted for publication June 3, 2005.

* Address correspondence to Dr Minamiya, Division of Thoracic Surgery, Department of Surgery, Akita University School of Medicine, 1-1-1 Hondo Akita City, 010-8543 Japan (Email: minamiya{at}med.akita-u.ac.jp).

PURPOSE: We recently developed a novel method for sentinel lymph node mapping using magnetic force. However, problems with the sterility and sensitivity of the magnetometer made intraoperative sentinel lymph node mapping impossible. The purpose of this study was to test the utility of a new, more sensitive, sterilizable magnetometer developed in our institute for in vivo sentinel lymph node mapping in patients with nonsmall cell lung cancer.

DESCRIPTION: Ferumoxides (magnetite) served as the tracer. Twenty patients with nonsmall cell lung cancer participated in the study. Each received 5 mL of ferumoxides, which were injected around their tumor. Magnetic force was then measured intraoperatively using the new sterilizable magnetometer.

EVALUATION: The in vivo sentinel lymph node detection rate was 80.0% (16 of 20). The accuracy, sensitivity, and false-negative rates were 100% (16 of 16), 100% (4 of 4) and 0% (0 of 12), respectively. Our preliminary study indicates that our new magnetometer enables in vivo sentinel lymph node mapping in patients with nonsmall cell lung cancer.

CONCLUSIONS: This device safely and accurately detected sentinel lymph nodes in nonsmall cell lung cancer patients.




This article has been cited by other articles:


Home page
ICVTSHome page
T. Ono, Y. Minamiya, M. Ito, H. Saito, S. Motoyama, H. Nanjo, and J. Ogawa
Sentinel node mapping and micrometastasis in patients with clinical stage IA non-small cell lung cancer
Interactive CardioVascular and Thoracic Surgery, October 1, 2009; 9(4): 659 - 661.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. Minamiya, M. Ito, Y. Hosono, H. Kawai, H. Saito, Y. Katayose, S. Motoyama, and J.-i. Ogawa
Subpleural injection of tracer improves detection of mediastinal sentinel lymph nodes in non-small cell lung cancer
Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 770 - 775.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. C. Detterbeck
Invited commentary
Ann. Thorac. Surg., January 1, 2006; 81(1): 330 - 330.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.